Aggregated price index with volume information
Summary:
- Medical Specialties stocks down 0.3% on average while median return down 0.7% in a day
- Medical Specialties stocks up 3.5% on average while median return up -0.2% in a week
- Medical Specialties stocks down 6.0% on average while median return down 10.0% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $SLNO 477.5%, $IRIX 53.0%, $BWAY 23.5%, $ECOR 15.0%, $ICCC 14.5%
- 1M losers are : Losers for past month are $BMRA -32.5%, $OFIX -39.8%, $DMTK -40.0%, $VNRX -44.9%, $CUTR -47.0%
- 1W winners are : Winners for past week are $SLNO 589.5%, $IRIX 15.5%, $ECOR 14.1%, $LNTH 12.4%, $THMO 12.0%
- 1W losers are : Losers for past week are $AVDL -9.2%, $DMTK -12.7%, $CUTR -13.3%, $NAOV -15.5%, $BMRA -19.6%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 12.5%, for the past 3 months is 10.1%
In the past month for a 5 days rolling window, the highest corrrelation is 33.6%, the lowest correlation is 1.9%, the latest correlation is 1.9%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 67.0% between ABT and AXNX
The lowest correlation is -39.8% between BEAT and CCEL
(Bloomberg) -- With weight-loss drugs that reduce the risk of heart attacks and diabetes potentially improving millions of lives, stock investors have had the somewhat unpleasant task of sussing out the impact on a host of health-care companies.Most Read from BloombergPakistan Rupee Set to Become Top Performing Currency Globally Europe’s Richest Royal Family Builds $300 Billion Finance EmpireTop Chinese Scientist Claims India Moon Landing Nowhere Near South PoleDianne Feinstein, Longest-Serving
Investors are optimistic about Zimmer Biomet (ZBH) on business recovery and expansion in emerging markets.
LITTLE ELM, Texas, September 29, 2023--Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2023 through September 30, 2023. The dividends will be paid on October 20, 202
Broadcastings Begin Saturday, September 30, 2023, at 3:30 PM ET New to The Street Announces its Four Corporate Interviews Airing on Newsmax and The FOX Business Network New to The Street's Broadcastings Begin Saturday, September 30, 2023, at 3:30 PM ET with the following interviews: 1). NuZee, Inc. 2). American Rebel Holdings, Inc (NASDAQ: AREB) ($AREB) 3). PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) 4). Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (
The company's current lineup includes the t:slim X2 and the newly cleared Mobi Insulin Pump, which management calls "the world's smallest durable insulin delivery system." Despite this progress on the regulatory front, Tandem has been bruised and battered on the stock market over the past year, as its financial results haven't been as good. The company's sales of insulin pumps have declined amid the challenging economy, leading to lower year-over-year revenue growth.
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Key Insights The projected fair value for Insulet is US$185 based on 2 Stage Free Cash Flow to Equity With US$164 share...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is how Align Technology (ALGN) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.